MSTR has clawed back 5% on the week to $122.81, a modest recovery from the depths of a 31% monthly decline — yet the short position that has been building since early May remains almost entirely intact.
The positioning picture has barely shifted since the June 8 earnings print. Short interest eased very slightly, down just 2.3% on the week to 15.0% of the free float — roughly 40.3 million shares still committed to the downside. That figure has been anchored in the 39–41 million share range for six consecutive weeks, suggesting shorts are not covering into this bounce. The borrow market continues to make patience cheap: cost to borrow ticked up 17% on the week but remains just 0.51%, an almost negligible carry cost. Availability has actually loosened, rising to 225% from 176% last Tuesday — meaning there are now more than two shares available to borrow for every one already lent. That is well within the normal range and far from any squeeze territory. The ORTEX short score sits at 59.6, easing fractionally from last week's high of 60.1 but still consistent with a bearish setup rather than a resolved one.
Options positioning offers the week's most notable divergence from the short book. Buyers have swung noticeably toward calls — the put/call ratio dropped to 0.93, almost two standard deviations below its 20-day average of 1.03. That is the lowest PCR reading in months and sits closer to the 52-week low of 0.76 than to the 52-week high of 1.44. Short sellers are holding firm; options traders are, for now, betting on continued recovery.
The Street remains broadly constructive but has been cutting targets. Canaccord Genuity trimmed its price target from $224 to $163 on June 3 while holding its Buy rating. Mizuho followed on June 1, lowering from $320 to $265, also keeping Outperform. The mean analyst target sits at around $352 — well above the current price — but the direction of recent moves is downward across most desks, reflecting the stock's sharp de-rating from its highs. The bull case rests on bitcoin per share accumulation: management reported BTC Yield of 22.8% in 2025 and has signalled no change to the buy-and-hold strategy. The bear case is structural — MSTR is a single-asset leveraged bitcoin vehicle with limited revenue diversification, and the Q1 2026 net loss (driven by unrealized bitcoin losses) illustrates how directly the income statement tracks crypto sentiment.
The institutional register tells an interesting sub-story. Capital Research and Management, the largest external holder, added 12.8 million shares in the most recent filing — taking its stake to 12.3% of shares. BlackRock added 3.1 million shares to reach just over 5%. Both moves were reported against the backdrop of a falling stock price, suggesting at least some large-cap institutional conviction at these levels. On the other side, company insiders — CEO Phong Le, CFO Andrew Kang, and the Chief Accounting Officer — all sold modest parcels on June 9 at prices around $123–125. The dollar amounts were small (Le's total was under $700k), and the trades score only a 1 on ORTEX's significance scale, but the direction adds a small note of caution.
With the next earnings event pencilled in for August 5, the tension between a call-heavy options market and a stubbornly large short book is worth watching — particularly if bitcoin continues to recover and tests whether that 40-million-share short position finally starts to feel expensive to hold.
See the live data behind this article on ORTEX.
Open MSTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
